MediLink Announces Global Clinical Trial Collaboration and Supply Agreement on YL201 Combination Therapy ...Middle East

PR Newswire - News
MediLink Announces Global Clinical Trial Collaboration and Supply Agreement on YL201 Combination Therapy
SUZHOU, China, Oct. 7, 2024 /PRNewswire/ -- MediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announced a global clinical trial collaboration and supply agreement with Amgen Inc. Amgen will lead a global clinical study to evaluate the...

Hence then, the article about medilink announces global clinical trial collaboration and supply agreement on yl201 combination therapy was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( MediLink Announces Global Clinical Trial Collaboration and Supply Agreement on YL201 Combination Therapy )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News